BackgroundCheck.run
Search For

Michael J Difilippantonio, 5613902 Flint Rock Rd, Rockville, MD 20853

Michael Difilippantonio Phones & Addresses

13902 Flint Rock Rd, Rockville, MD 20853    301-4600404   

2004 Baltimore Rd, Rockville, MD 20851   

8811 Colesville Rd, Silver Spring, MD 20910   

Sandy Hook, CT   

1732 Whitney Ave, Hamden, CT 06517    203-2878499   

145 Harmon St, Hamden, CT 06517    203-2487469   

East Haven, CT   

Newtown, CT   

13902 Flint Rock Rd, Rockville, MD 20853    301-3653582   

Work

Position: Clerical/White Collar

Education

Degree: High school graduate or higher

Mentions for Michael J Difilippantonio

Resumes & CV records

Resumes

Michael Difilippantonio Photo 10

Program Manager, Division Of Cancer Treatment And Diagnosis

Location:
13902 Flint Rock Rd, Rockville, MD 20853
Industry:
Research
Work:
DCTD, NCI, NIH since May 2010
Program Manager for Therapeutic and Diagnostic Initiatives
Section of Cancer Genomics, Genetics Branch, CCR, NCI, NIH Jan 2001 - Apr 2010
Staff Scientist
NIH Jul 1998 - Dec 2000
Postdoctoral Fellow
Yale University School of Medicine Oct 1997 - Jun 1998
Postdoctoral Fellow
Education:
Yale University 1992 - 1997
PhD, Genetics / Immunology
The University of Connecticut 1989 - 1990
Certificate, Cytogenetics
The University of Connecticut 1985 - 1989
BS, Molecular and Cellular Biology, Genetics
Skills:
Cancer Research, Genetics, Cancer, Immunology, Pcr, Drug Discovery, Molecular Biology, Cell Culture, Dna, Fluorescence Microscopy, Bioinformatics, Protein Chemistry, Life Sciences, Protein Purification, Cell, Molecular Genetics, Microscopy, Western Blotting, Cell Biology, Polymerase Chain Reaction, Confocal Microscopy, Critical Thinking, Data Analysis, Process Management
Interests:
Education
Languages:
English
German
Michael Difilippantonio Photo 11

Michael Difilippantonio

Michael Difilippantonio Photo 12

Michael Difilippantonio

Publications & IP owners

Us Patents

Composition For Detecting The Response Of Rectal Adenocarcinomas To Radiochemotherapy

US Patent:
2008002, Jan 24, 2008
Filed:
Jan 12, 2005
Appl. No.:
10/585725
Inventors:
Thomas Ried - Bethesda MD, US
Michael J. Difilippantonio - Rockville MD, US
Marian Grade - Goettingen, DE
Heinz Becker - Gottingen, DE
Torsten Liersch - Gottengen, DE
Assignee:
The Gov.of US as represented by Sec.Dept.of Health - Bethesda MD
International Classification:
C12Q 1/68
C07H 21/04
C07K 16/00
US Classification:
435 6, 530350, 5303871, 536 235
Abstract:
A cDNA array (9984 genes) was used for expression profiling in rectal adenocarcinoma. The expression data were correlated to responsiveness to chemotherapy followed by radiotherapy. A set of 54 genes was found that were differentially expressed in responders vs. non-responders. The genes may be used as prognostic markers for determining whether a rectal adenocarcinoma is responsive to radiochemotherapy.

Composition For Detecting The Response Of Rectal Adenocarcinomas To Radiochemotherapy

US Patent:
2015024, Sep 3, 2015
Filed:
Oct 6, 2014
Appl. No.:
14/507707
Inventors:
- Rockville MD, US
Heinz Becker - Goettingen, DE
Torsten Liersch - Goettingen, DE
Michael J. Difilippantonio - Rockville MD, US
Marian Grade - Goettingen, DE
International Classification:
C12Q 1/68
Abstract:
A cDNA array (9984 genes) was used for expression profiling in rectal adenocarcinoma. The expression data were correlated to responsiveness to chemotherapy followed by radiotherapy. A set of 54 genes was found that were differentially expressed in responders vs. non-responders. The genes may be used as prognostic markers for determining whether a rectal adenocarcinoma is responsive to radiohemotherapy.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.